HYRO AI INC.

Hyro is a New York City-based technology company specializing in AI-driven conversational platforms for the healthcare sector. Founded in 2014 by Israel Krush and Rom Cohen, the company's mission is to simplify interactions across all digital channels, enabling healthcare organizations to automate tasks, streamline communications, and enhance patient access to care. Its primary headquarters are located at 149 5th Avenue, 9th Floor, New York, NY, with an additional R&D center in Tel Aviv-Yafo, Israel.

The company's core offerings include AI-powered virtual assistants and chatbots, collectively known as AI agents, which form an adaptive communications platform. These solutions leverage natural language processing (NLP) and natural language understanding (NLU) to automate routine patient interactions such as scheduling management, prescription support, and FAQ resolution across various channels including voice calls, websites, mobile apps, and SMS. Hyro's platform is designed to be HIPAA-compliant, serving health systems, hospitals, and payers to improve operational efficiency and patient engagement.

Hyro is a privately held company that has garnered significant investment, including a $45 million strategic growth funding round in October 2025, which brought its total funding to $95 million and doubled its valuation. The company has been recognized as a leader in responsible AI agents for healthcare, being named to the 2026 New York Digital Health 100 and a "Fierce 15" Company of 2026. Its AI platform is deployed across more than 45 health systems, supporting over 30 million patients, and is capable of resolving up to 85% of routine patient interactions.